About this trial
Last updated 5 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 6 years ago
What is this trial about?
What are the Participation Requirements?
Inclusion Criteria for patients:
- age ≥ 18 years
- newly diagnosed with cancer within 15 weeks prior to informed consent signature
- planned to receive first cycle of their first-line pharmacological anti-cancer
treatment in an outpatient centre (intravenous, oral or subcutaneous)
- signed informed consent
Exclusion Criteria for patients:
- not sufficiently literate in German language to understand written information or
follow an interview
- recurrence of cancer disease
- cared by a palliative care team
- being treated solely with surgical or radiation therapy